Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Astra Zeneca | Stoccolma | Salute | Prodotti farmaceutici | 2,28 Bln SEK | 32,1x | 3,2 | 1.471 SEK | -0,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 10,6% Rialzo | Fai l’upgrade a Pro+ | |
Swedish Orphan Biovitrum | Stoccolma | Salute | Prodotti farmaceutici | 104,27 Mrd SEK | 29,8x | 2,13 | 302,40 SEK | -1,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 20,2% Rialzo | Fai l’upgrade a Pro+ | |
Sectra | Stoccolma | Salute | Attrezzature e forniture medicali | 54,83 Mrd SEK | 122,6x | 7 | 284,70 SEK | 0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -15,6% Ribasso | Fai l’upgrade a Pro+ | |
Getinge | Stoccolma | Salute | Attrezzature e forniture medicali | 45,52 Mrd SEK | 26,9x | -1,09 | 170,50 SEK | -0,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 23,7% Rialzo | Fai l’upgrade a Pro+ | |
Camurus AB | Stoccolma | Salute | Prodotti farmaceutici | 33,46 Mrd SEK | 122,2x | -2,9 | 570 SEK | 3,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 34,6% Rialzo | Fai l’upgrade a Pro+ | |
Vitrolife | Stoccolma | Salute | Attrezzature e forniture medicali | 30,68 Mrd SEK | -8,1x | 0,01 | 224,80 SEK | -0,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 24% Rialzo | Fai l’upgrade a Pro+ | |
Medicover | Stoccolma | Salute | Fornitori e servizi sanitari | 26,57 Mrd SEK | 117,2x | 0,8 | 175,80 SEK | -0,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 24,8% Rialzo | Fai l’upgrade a Pro+ | |
Bonesupport | Stoccolma | Salute | Prodotti farmaceutici | 24,24 Mrd SEK | 267,5x | -4,53 | 366,40 SEK | -1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 5,5% Rialzo | Fai l’upgrade a Pro+ | |
Elekta | Stoccolma | Salute | Attrezzature e forniture medicali | 24,22 Mrd SEK | 24,2x | 16,15 | 65,05 SEK | 1,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 9,2% Rialzo | Fai l’upgrade a Pro+ | |
Vimian Group AB | Stoccolma | Salute | Prodotti farmaceutici | 23,33 Mrd SEK | 64.108,2x | 77,99 | 44,85 SEK | 0,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 15,4% Rialzo | Fai l’upgrade a Pro+ | |
BioArctic | Stoccolma | Salute | Ricerca medica e biotecnologica | 16,91 Mrd SEK | -72,6x | 0,38 | 193,10 SEK | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
AddLife | Stoccolma | Salute | Attrezzature e forniture medicali | 16,26 Mrd SEK | 139,4x | -2,3 | 133,10 SEK | 1,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 25,3% Rialzo | Fai l’upgrade a Pro+ | |
Xvivo Perfusion AB | Stoccolma | Salute | Attrezzature e forniture medicali | 14,87 Mrd SEK | 71,6x | 0,1 | 480 SEK | 1,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 16,9% Rialzo | Fai l’upgrade a Pro+ | |
Biotage | Stoccolma | Salute | Attrezzature e forniture medicali | 12,32 Mrd SEK | 47,6x | 2,46 | 152,30 SEK | 0,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 31,8% Rialzo | Fai l’upgrade a Pro+ | |
Biogaia | Stoccolma | Salute | Prodotti farmaceutici | 10,77 Mrd SEK | 32x | -1,38 | 107 SEK | 1,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 40,3% Rialzo | Fai l’upgrade a Pro+ | |
Implantica AG | Stoccolma | Salute | Attrezzature e forniture medicali | 10,40 Mrd SEK | -38x | 1,57 | 36,10 SEK | -1,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 48,2% Rialzo | Fai l’upgrade a Pro+ | |
Arjo | Stoccolma | Salute | Attrezzature e forniture medicali | 9,39 Mrd SEK | 18,6x | 0,64 | 34,30 SEK | -0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 16,3% Rialzo | Fai l’upgrade a Pro+ | |
Ambea | Stoccolma | Salute | Fornitori e servizi sanitari | 8,08 Mrd SEK | 14x | 0,16 | 96 SEK | 0,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 25,6% Rialzo | Fai l’upgrade a Pro+ | |
Swedencare | Stoccolma | Salute | Prodotti farmaceutici | 7,88 Mrd SEK | 127x | -4,06 | 49,60 SEK | 1,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 16,3% Rialzo | Fai l’upgrade a Pro+ | |
Surgical Science Sweden | Stoccolma | Salute | Attrezzature e forniture medicali | 7,60 Mrd SEK | 39,4x | -1,63 | 148,20 SEK | -0,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 26,1% Rialzo | Fai l’upgrade a Pro+ | |
Attendo International publ AB | Stoccolma | Salute | Fornitori e servizi sanitari | 7,50 Mrd SEK | 19,4x | 0,39 | 48,60 SEK | 0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 26,4% Rialzo | Fai l’upgrade a Pro+ | |
Raysearch Laboratories | Stoccolma | Salute | Attrezzature e forniture medicali | 7,13 Mrd SEK | 40,7x | 0,24 | 208 SEK | 0,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 25,6% Rialzo | Fai l’upgrade a Pro+ | |
Cellavision | Stoccolma | Salute | Attrezzature e forniture medicali | 5,24 Mrd SEK | 35,2x | 0,08 | 218,50 SEK | -2,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 18,6% Rialzo | Fai l’upgrade a Pro+ | |
Probi | Stoccolma | Salute | Prodotti farmaceutici | 3,97 Mrd SEK | 364,4x | -17,95 | 347 SEK | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Flerie AB | Stoccolma | Salute | Prodotti farmaceutici | 3,83 Mrd SEK | -459,6x | 51,51 SEK | 6,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 46,1% Rialzo | Fai l’upgrade a Pro+ | ||
Bioinvent | Stoccolma | Salute | Ricerca medica e biotecnologica | 2,98 Mrd SEK | -7,2x | 0,24 | 43 SEK | -2,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Medistim ASA | Stoccolma | Salute | Attrezzature e forniture medicali | 2,78 Mrd SEK | 27,8x | -1,99 | 154,68 SEK | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
BICO Group | Stoccolma | Salute | Attrezzature e forniture medicali | 2,33 Mrd SEK | -1,4x | 0,21 | 32,66 SEK | -2,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Hansa Biopharma | Stoccolma | Salute | Ricerca medica e biotecnologica | 2,19 Mrd SEK | -2,9x | -0,09 | 32,50 SEK | -0,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Devyser Diagnostics AB | Stoccolma | Salute | Ricerca medica e biotecnologica | 2,18 Mrd SEK | -30,8x | 1,3 | 130 SEK | -1,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 14,9% Rialzo | Fai l’upgrade a Pro+ |